GSK chases Astra with start of big anaemia drug trials
November 24, 2016 at 07:13 AM EST
LONDON, Nov 24 (Reuters) - GlaxoSmithKline has started pivotal trials of an experimental anaemia drug, chasing AstraZeneca in the race to develop a medicine that mimics the body's response to high altitude.
